Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia (Q34119559)

31 July 2017

title

Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia (English)

1 reference

31 July 2017

Forray C

1

1 reference

31 July 2017

Noble SA

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

published in

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

2073-2094

1 reference

Recent developments in the surgical management of benign prostatic hyperplasia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Characterization of an α1D‐adrenoceptor mediating the contractile response of rat aorta to noradrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

A 12-week placebo-controlled double-blind study of prazosin in the treatment of prostatic obstruction due to benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Long-term treatment of benign prostatic hyperplasia with alfuzosin: a 24-30 month survey. BPHALF Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Prostatic alpha 1-adrenoceptors and uroselectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Recent advances in the identification of alpha1- and alpha2-adrenoceptor subtypes: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antag

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

The effects of SB 216469, an antagonist which discriminates between the alpha 1A-adrenoceptor and the human prostatic alpha 1-adrenoceptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Effect of KMD-3213, an alpha 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

A modification of receptor theory. 1956

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Depressant effects of hypoxia and hypoglycaemia on neuro-effector transmission of guinea-pig intestine studied in vitro with a pharmacological model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

Pharmacological options in the treatment of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2073

10.1517/13543784.8.12.2073

21 January 2018

Identifiers

DOI

1 reference

release_o4ptpawuubdahm5u247icjfypy

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o4ptpawuubdahm5u247icjfypy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference